Lympo

Shivom Partners with Lympo to Incentivise Fitness Goers

Lympo

Shivom in cooperation with Lympo will provide fitness goers token incentives when accomplishing daily fitness challenges and completing healthcare questionnaires this summer.

London, United Kingdom – May 23, 2019 – Shivom, a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, has partnered with Lympo, a free mobile app that allows you to earn money just for walking, running or even squatting. Complete these daily challenges, receive token rewards to be redeemed in-app for healthy lifestyle goods and services.

Through this partnership, Shivom and Lympo this summer will invite it’s users to complete select daily challenges via the Lympo app. This partnership is about conducting joint challenges which support each other’s respective ecosystems and missions centred around fitness, wellness and healthcare. The first co-branded challenge will be made available June 15th; asking users to complete a 4 km run and additionally sign up to Shivom’s platform and complete a health questionnaire in order to receive LYM and OMX tokens.

Shivom aims to onboard new customers onto Shivom’s platform, which provides customers with the ability to purchase DNA-based and other personalized healthcare products and services; to earn tokens via unique healthcare-related tasks and programs; and the opportunity to directly participate in and earn compensation if desired when providing data for clinical research. Shivom recently launched its ‘Shop 1.5’ — the first cut of Shivom’s consumer marketplace, which provides consumers with unique incentives and the ability to purchase direct-to-consumer genetic testing products either by OMX token or fiat payment. [hyperlink to press release].

The Lympo application is available for both iOS and Android and provides customers with a simple way to get rewarded for getting fit. Along with the incentives of data ownership, Lympo creates incentives through tokenized rewards. By participating in social challenges and documenting benchmarks, users can earn Lympo tokens, which they can exchange for products in the Lympo ecosystem. Jonušė, Chief Executive Officer of Lympo hopes this will have benefits at both a personal and a corporate level. Since the ICO, Lympo, has attracted 136,000 users, nearly 13,000 of whom are active daily, with over 1.6 million challenges completed. It’s already the number one fitness app in South Korea, and is partnering with major brands like Dallas Mavericks and Oxygen.

“We are thrilled to partner with Lympo to jointly sponsor daily fitness challenges and to offer token incentives via completion of select tasks on Lympo’s app and Shivom’s platform. Both organizations are focused on driving fitness and motivating individuals to make healthy lifestyle choices. There are considerable synergies as Lympo offers daily fitness challenges in a gamified manner while Shivom offers individualized healthcare products and services as well as the opportunity to monetize on the use of personal data for clinical research purposes. The partnership is also notable for the broader industry as two token projects converge for cross platform engagement and provide opportunities to earn and utilize both OMX and LYM native tokens — dynamics increasingly necessary for growing healthy token economies and ecosystems” according to Henry Ines, CEO of Shivom.

For more information about Shivom please visit here
To read more about our affiliation with Living DNA please visit here
To read more about our affiliation with Vitl please visit here
To read more about our affiliation with Chronomics please visit here

About Shivom
Shivom is a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed. By utilising innovative technologies such as blockchain and machine-learning algorithms, we are able to democratise genomics.

Our mission is to bring exponential value to our end-users within the genomics industry. We believe that the unique combination of our in-depth knowledge for genomics, mixed with deep-rooted backgrounds in cryptography and AI is essential in the democratisation of genomics and healthcare data.

Learn more about our direct-to-consumer solutions here

Shivom Social Channels:
Official Homepage: shivom.io
Twitter (English): @projectshivom
Youtube: Shivom’s Channel
Telegram: Shivom Announcements
Facebook: @projectshivom
Instagram: @projectshivom
Medium: Shivom Official
LinkedIn: @projectshivom

About Lympo
Lympo is making the world healthier by rewarding people for exercising and leading healthier lives. With the help of blockchain technology and fitness gamification, users are rewarded with LYM tokens through the Lympo Run app, for completing walking and running challenges. These tokens can then be used to purchase quality sporting goods by top global brands in Lympo Shop – the first-ever online shop to accept fitness token payments.

We are actively building a complete data-sharing ecosystem, which in the future will connect fitness and wellness stakeholders (personal trainers, gyms, sports events, brands) with users via a blockchain based reward system, linked to users’ health and fitness data. We will also offer a place to collect, store and monetize this valuable data from a variety of health and fitness tracking apps or wearables.

Ultimately, the goal is to create a win-win situation for each platform participant – the users will be able to monetize their health and fitness data via the LYM utility token and the businesses, in return, will receive access to a tech-savvy community, passionate about healthy living.

For more information about Lympo please visit here

Recommended

Shivom

Shivom Releases Updated Marketplace, Enabling OMX Token Payment via MetaMask

Shivom

Shivom releases ‘Shop 1.5’ which provides consumers with unique incentives and the ability to purchase direct-to-consumer genetic testing products either by OMX token or fiat payment.

London, United Kingdom – May 23, 2019 – Shivom, a biotechnology data discovery and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, has released its latest consumer marketplace ‘Shop 1.5’ along with additional updates to the user creation and login. This release will enable consumers with the ability to purchase genetic testings products either by OMX payment or fiat. Additionally, the team has made updates separating the login and creation for enterprise and consumer account and to the health and lifestyle questionnaire within the profile section.

The release will be live to the public at 12:00 pm GMT on 23rd May.  This is a major milestone for Shivom as it will not only enable consumers to purchase directly within Shivom’s marketplace via either OMX token or fiat payment but also bring mainstream partners to Shivom’s innovative blockchain eco-system.

The first group of partners featured on Shop 1.5 include Vitl, Living DNA and Chronomics, which provide ancestry, vitamin and cholesterol and epigenetic testing, respectively. Consumers purchasing any of these kits or services will need to agree to both Shivom and its partners’ terms of use and privacy policies.

At this time, customers are only able to purchase Chronomics epigenetic test with OMX tokens, whilst Living DNA and Vitl’s kits can be purchased with fiat via our partner’s checkout page. This allows users who don’t have tokens to be able to obtain their genetic data file and reports without having to buy tokens from an exchange. Customers who purchase with OMX tokens will receive an automatic email providing a voucher code.  This can then be redeemed on Chronomics website for one month’s subscription of EpiPlanner and a test kit. Please be aware, a minimum subscription of 12 months is required.

All of our D2C partners have undergone a thorough screening from our research and development (R&D) team prior to being granted promotional status within the marketplace. Shivom implements quality control procedures for its marketplace items and criteria which covers a variety of considerations to include data privacy, security and scientific quality (e.g., is a report evidence-based). When products or services are not supported by adequate clinical evidence, Shivom’s R&D team may request further evidence to support the potential partner’s case. Here is the link to our blog which provides an in-depth explanation of the reasoning we have for listing Vitl, Living DNA and Chronomics on our marketplace.

To mark this major milestone, for a limited time only Shivom is offering several exciting promotions. Customers who purchase either LivingDNA or Vitl kits and upload their data on Shivom’s platform will earn OMX tokens and also be eligible to receive special discounts or rewards on select products or services offered by Shivom and its partners (to be separately announced).

Additionally, for a limited time, only customers are also able to purchase Chronomics EpiPlanner Test Kit + 1 Month Subscription for only 1,000 OMX! That’s right, you read that correctly; for ~ $1 USD you can get your hands on this kit. Don’t miss out on this incredible opportunity!

“Today’s Shop 1.5 release stems from the collective hard work, focus and diligent efforts of our tech, science and business teams over the past 12 months. This release provides our early supporters with the ability to earn rewards for participating in our blockchain-based ecosystem and utilize either OMX tokens or fiat to procure top of the line kits from our curated product offerings. Once on our platform, consumers will not only have control over their data and be able to gain considerable health and wellness insights but also have the ability to participate in clinical research and even monetize on personal data if desired. We’re proud of early progress and also look forward to our upcoming MVP release, which will mark another significant milestone and showcase the first cut of our enterprise solution offerings and clinical functionalities.” said Henry Ines, CEO of Shivom.

For more information about Shivom please visit here
To read more about our affiliation with Living DNA please visit here
To read more about our affiliation with Vitl please visit here
To read more about our affiliation with Chronomics please visit here

About Shivom
Shivom is a biotechnology data discovery and analysis company optimising the way DNA is shared, secured and analysed. By utilising innovative technologies such as blockchain and machine-learning algorithms, we are able to democratise genomics.

Our mission is to bring exponential value to our end-users within the genomics industry. We believe that the unique combination of our in-depth knowledge for genomics, mixed with deep-rooted backgrounds in cryptography and AI is essential in the democratisation of genomics and healthcare data.

Learn more about our direct-to-consumer solutions here

Shivom Social Channels:
Official Homepage: shivom.io
Twitter (English): @projectshivom
Youtube: Shivom’s Channel
Telegram: Shivom Announcements
Facebook: @projectshivom
Instagram: @projectshivom
Medium: Shivom Official
LinkedIn: @projectshivom

Recommended

Shivom

Here’s How Shivom Chooses it’s Marketplace Partners

Shivom

This week, Shivom will launch its first iteration of our direct-to-consumer health management marketplace.  In this post, we will be providing information to the community and prospective partners about how we determine which products and companies are listed on our platform.

Shivom’s mission is to not only optimize how DNA is shared, secured and analysed but to bring exponential value to our end-users. With this mission comes the responsibility to make some pretty tough decisions through and through. One of these decisions is choosing which companies Shivom would want to interact with within our eco-system. When our team started working on ‘Shop 1.5’ Shivom understood that we shouldn’t strive to be just a marketplace promoting every type of genetic testing product we could get our hands on. This business model not only has problems with scalability but additionally lowers the quality or value we bring to our audience. For these reasons and many more, our team developed quality control and criteria which are used to decide which partners should be able to gain entry to the marketplace.

The first part of our review is about companies’ data privacy and security policies. The first question we ask is, do you share data with third-parties? The second question we ask is, do you sell or utilise the user’s data in order to generate revenue? If the answer is yes to either one of these questions, straight off the back the company would be eliminated from being able to join our marketplace.

In the second part of the review, our team will determine the quality of the report and determine whether it brings any value or if it is B*** S***. A Great example of this is when I recently saw on a competitor’s website that they were sequencing a user’s DNA in order to find out what kind of t-shirt looked best on them (v-neck or crew).

The third part of our review is whether the product and or company brings value to the eco-system. For example, if someone recently purchased Living DNA’s 3-in-1 Ancestry Kit they might also be interested in learning about their nutrition and cholesterol. Instead of having to purchase an entire kit we look at products which allow people to use their Raw Genetic data gained from the Ancestry KIt instead of having to re-swab, prick or take a faecal sample all over again. Additionally, we are also looking at which products are complementary to each other and could go hand-in-hand

In case you were wondering what the reasons were for choosing Vitl, Living DNA and Chronomics for our first iteration, I’ve included below an in-depth explanation.

Vitl
Vitl products not only have a high rate of positive customer feedback (e.g. 91% of customers rated Vitl products as ‘Excellent’ on Trustpilot), the team is comprised
of experts in their field; such as geneticists, nutritionists who understand the science and the practical aspects of healthy nutrition. Vitl uses the latest innovative technologies, such as; artificial intelligence. Additionally, the company uses credible vendors and laboratories for their tests(e.g. UKAS-accredited and CQC-registered blood testing facilities) as well as Illumina CSPro Certified Service Providers in Europe and the USA for DNA testing. Whilst other brands may test for a larger number of less well-researched traits, Vitl emphasizes quality over quantity. They only cover traits based on the strongest, peer-reviewed evidence to ensure users are getting the most reliable results.

Lastly, similar to Shivom’s philosophy of combining different omics technologies to gain insight, Vitl enables the integration of DNA data alongside blood and dietary results and lifestyle information. This is important because supplement recommendations or lifestyle advice cannot be made on DNA information alone, but taken alongside current blood vitamin levels and diet that are measured in a longitudinal way.

Living DNA
Living DNA launched back in 2016 as a collaboration of more than 100 scientists, researchers and genetic experts. We added Living DNA as a partner to our ecosystem because they provide precise ethnic estimates of ancestry testing. The 3-in-1 test covers the biggest number of genetic populations, which translates to the most accurate genetic percentages and offers unrivalled worldwide regional and sub-regional detail. The test incorporates three separate tests in one, giving the customer more for their money than any other ancestry tests on the market right now.

Additionally, instead of just getting your basic family ancestry (autosomal DNA), you also get an analysis along your mother line (derived from mitochondrial DNA) and your father line (derived from the male-specific y-chromosome). Living DNA is a holder of ISO:27001 certification, which demonstrates good protection and security for personal and genetic data. As DNA samples are only connected to unique ID numbers, not even its staff members will know the identity of its users. The company works with “Show Racism the Red Card,” a group that fights racism to provide a safe space to reduce racist ideas and attitudes. Lastly, Living DNA provides the raw data of all test results which can be used on the Shivom precision medicine platform to foster research and fight rare diseases.

Chronomics
Epigenetic testing is relatively new to the direct-to-consumer testing market. We partnered with Chronomics because of their impeccable experience in this field. Our CSO, Dr Axel Schumacher is one of the many pioneers of epigenetics and worked alongside some of the Chronomics team members.

Epigenetics is the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself. Epigenetic testing offers additional value to genomic testing, in particular, allowing individuals to analyse how environmental and lifestyle choices affect the body and how these patterns change over time. By monitoring epigenetic patterns, it is possible to collect actionable insight allowing for a personalized improvement plan. Most importantly, Chronomics provides users with the ability to gain access to their raw data which can be managed, stored and monetized on Shivom.

For more information about Shivom please visit here
To read more about our affiliation with Living DNA please visit here
To read more about our affiliation with Vitl please visit here
To read more about our affiliation with Chronomics please visit here

About Shivom
Shivom is a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed. By utilising innovative technologies such as blockchain and machine-learning algorithms, we are able to democratise genomics.

Our mission is to bring exponential value to our end-users within the genomics industry. We believe that the unique combination of our in-depth knowledge for genomics, mixed with deep-rooted backgrounds in cryptography and AI is essential in the democratisation of genomics and healthcare data.

Learn more about our direct-to-consumer solutions here

Shivom Social Channels:
Official Homepage: shivom.io
Twitter (English): @projectshivom
Youtube: Shivom’s Channel
Telegram: Shivom Announcements
Facebook: @projectshivom
Instagram: @projectshivom
Medium: Shivom Official
LinkedIn: @projectshivom

Recommended

Epigenetic

Shivom Adds Chronomics to the Marketplace, Offering Customers Epigenetic Testing with OMX Token Payment

Epigenetic

Chronomics EpiPlanner Epigenetic Test will provide Shivom’s customers with lifestyle and environment indicators to reveal an overall picture of your health.

London, United Kingdom – May 20, 2019 – Shivom, a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, has teamed up with Chronomics, an online health services company which helps you understand how your environment and lifestyle choices are impacting your body and mind at the level of your DNA; to offer Chronomics EpiPlanner Epigenetic Test within Shivom’s marketplace. Through this affiliation, Shivom’s customers can discover lifestyle and environment indicators to reveal an overall picture of your health.

Epigenetic

Through a simple saliva test kit, the test will measure an epigenetic marker called DNA methylation, which can shift with environment and lifestyle. Customers who get the kit can log onto a web portal to find out their “biological age” — a well-established metric built on research by Chronomics in-house scientists. Scientists refer to biological age as to how old a person seems. Currently, the most accurate way to measure biological age is with epigenetics. This means that your age is NOT just a number. Your age is whatever you choose to make it.

For a limited period of time, Shivom plans to offer customers who sign up for Chronomics’ services or purchase other newly listed DNA products on Shivom’s marketplace with unique incentives ranging from token rewards to discounted reports and genetic counselling sessions via Shivom partners and affiliates. “In addition to recently added Living DNA ancestry and Vitl’s Vitamin and Cholesterol Blood Test Kit, we are now also pleased to offer Chronomics’ pioneering Epigenetic Test Kit, which will provide our customers with insights on their metabolic state, biological age and overall health as a result of diet / lifestyle choices and exposure to pollution. Notably, as the first consumer testing kit of its kind, Chronomics’ Epigenetics kit will also be able to be procured via OMX tokens. This is a very exciting development not only for our ecosystem but also for the broader blockchain & crypto industry.” Says Henry Ines, CEO of Shivom.

For more information about Shivom please visit here
To read more about our affiliation with Living DNA please visit here
To read more about our affiliation with Vitl please visit here

About Shivom
Shivom is a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed. By utilising innovative technologies such as blockchain and machine-learning algorithms, we are able to democratise genomics.

Our mission is to bring exponential value to our end-users within the genomics industry. We believe that the unique combination of our in-depth knowledge for genomics, mixed with deep-rooted backgrounds in cryptography and AI is essential in the democratisation of genomics and healthcare data.

Learn more about our direct-to-consumer solutions here

Shivom Social Channels:
Official Homepage: shivom.io
Twitter (English): @projectshivom
Youtube: Shivom’s Channel
Telegram: Shivom Announcements
Facebook: @projectshivom
Instagram: @projectshivom
Medium: Shivom Official
LinkedIn: @projectshivom

About Chronomics
Chronomics has built an online digital platform that uses epigenetics to give people the knowledge of how their environment and lifestyle is imprinting itself on their DNA and affecting their health. From a simple saliva test, users have access to the knowledge of how their environment and lifestyle is affecting them. Combined with the power to enact change through user recommendations to enable them to live healthier and happier for longer.

#HackYourDNA with Chronomics

For more information about Chronomics please visit here

Recommended

Vitl

Shivom Adds Vitl to the Marketplace, Offering Customers Vitamin & Cholesterol Blood Tests

Vitl

The VITL Vitamin and Cholesterol Blood Test will provide Shivom’s customers with the ability to track and improve key health markers so you can feel your best more often.

London, United Kingdom – May 14, 2019 – Shivom, a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, has teamed up with Vitl who have partnered with experienced doctors, geneticists, biomedical scientists and expert nutritionists from leading organisations around the world, including King’s College London, The Institute for Optimum Nutrition and the European Nutrition Leadership Platform; to offer Vitl’s Vitamin and Cholesterol Blood Test within Shivom’s marketplace. Through this affiliation, Shivom’s customers can track and improve key health markers so you can feel your best more often.

The blood kit which has been developed by Vitl enables consumers via at home simple finger-prick blood test you’ll get a thorough analysis of the key nutrients that have the greatest impact on wellbeing and long-term health. This can be done from the comfort of your own home with no large needles or waiting rooms. The customer will also receive personalised dietary and lifestyle recommendations from a qualified nutritionist, and a bespoke pack of vitamins tailored to your results.

For a limited period of time, Shivom plans to offer unique incentives ranging from token rewards to discounted reports and genetic counselling sessions via Shivom partners and affiliates. “In addition to Living DNA’s ancestry kits, we are now pleased to also offer Vitl’s Vitamin and Cholesterol Blood Test kit, which will provide our customers with deep insights, such as understanding which nutrients are most impactful for well-being and long term health, and the ability to receive customized dietary and lifestyle recommendations from a qualified nutritionist. Customized vitamin supplements will also now be possible to offer our customers based on their personal health and genomic profile. As is the case with all of our curated products, Vitl’s products are world class, grounded in science and are manufactured and processed in accordance with leading international standards and certifications.” Says Henry Ines, CEO of Shivom.

For more information about Shivom please visit here
To read more about our affiliation with Living DNA please visit here

About Shivom
Shivom is a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed. By utilising innovative technologies such as blockchain and machine-learning algorithms, we are able to democratise genomics.

Our mission is to bring exponential value to our end-users within the genomics industry. We believe that the unique combination of our in-depth knowledge for genomics, mixed with deep-rooted backgrounds in cryptography and AI is essential in the democratisation of genomics and healthcare data.

Learn more about our direct-to-consumer solutions here

Shivom Social Channels:
Official Homepage: shivom.io
Twitter (English): @projectshivom
Youtube: Shivom’s Channel
Telegram: Shivom Announcements
Facebook: @projectshivom
Instagram: @projectshivom
Medium: Shivom Official
LinkedIn: @projectshivom

About Vitl
We understand finding the time to stay healthy is increasingly difficult when you lead a busy, exciting life. So we created VITL to help do the hard work for you. Reinventing the approach to daily nutrition, our products are developed by VITL’s team of leading experts using the highest quality, sustainably sourced ingredients to help you stay healthy and feel great.

Thoughtfully designed to fit effortlessly and conveniently with your busy day, we’re on a mission to make staying healthy a little more achievable.

Love life? #LiveLifeBetter with VITL

For more information about Vitl please visit here

Recommended

Ancestry Kit_Living_DNA_Shivom

Shivom Adds Living DNA to the Marketplace, Offering Customers a 3-in-1 ancestry Kit

Ancestry Kit_Living_DNA_Shivom

Living DNA’s 3-in-1 ancestry kit will provide Shivom’s customers with the ability to trace their origins back via maternal ancestors, and see how they moved around the world over thousands of years.

London, United Kingdom – April 15, 2019 – Shivom, a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, has now been approved as an affiliate of Living DNA. Through this affiliation, Shivom will redirect customers to the Living DNA website in order to purchase their 3-in-1 ancestry kit.

The ancestry kit which has been developed by Living DNA enables consumers to discover their ancestry from around the world via a simple cheek swab, providing exceptional regional details. Many of their customers have used this opportunity to travel to their ancestral homelands. Living DNA can show you your recent family ancestry covering up to 15 generations, and your deep ancestry with Motherline and Fatherline (if male) results. Additionally, the company have developed an improved Single nucleotide polymorphisms (SNP) genotyping platform that has been tailored to match the technical requirements of the different statistical methodologies they use to analyse customer data. Sirius, the new chip, has been designed using the Axiom® technology from Affymetrix / Thermo Scientific, which allows great flexibility to match every feature of the chip to their products.

“We are excited to offer Living DNA’s kits within our marketplace. Living DNA, along with parent company DNA Worldwide Group, shares the same high standards of excellence and commitment to consumer data ownership and security as Shivom. Living DNA’s kit is not only rated one of the best ancestry kits on the market, but they are also accredited and certified by leading international standards.” Says Henry Ines, CEO of Shivom.

For more information about Shivom please visit:
https://www.shivom.io

About Shivom
Shivom is a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed. By utilising innovative technologies such as blockchain and machine-learning algorithms, we are able to democratise genomics.

Our mission is to bring exponential value to our end-users within the genomics industry. We believe that the unique combination of our in-depth knowledge for genomics, mixed with deep-rooted backgrounds in cryptography and AI is essential in the democratisation of genomics and healthcare data.

Learn more about our direct-to-consumer solutions here

Shivom Social Channels:
Official Homepage: shivom.io
Twitter (English): @projectshivom
Youtube: Shivom’s Channel
Telegram: Shivom Announcements
Facebook: @projectshivom
Instagram: @projectshivom
Medium: Shivom Official
LinkedIn: @projectshivom

About Living DNA
Living DNA is a high definition of DNA testing that challenges the concept of race and tackles ideas of separation through our ‘One Family, One World’ education programmes. With 75% of clients living overseas, we do this globally.

Presenting self-truth and letting science talk helps people change their lives. Putting ancestry into context allows people to celebrate not only how unique they are but also understand how we are all connected going back through history.

For more information about Living DNA please visit:
www.livingDNA.com

Recommended

Cleveland Clinic-Family-Care-Path-Shivom

Shivom Partners with Family Care Path a Spin-Off Company from Cleveland Clinic

Cleveland Clinic-Family-Care-Path-Shivom

Family Care Path’s clinically-validated MyLegacy and CarePathConnect application will provide new ways for Shivom’s customers to take action on their genetic risk for certain hereditary conditions.

London, United Kingdom – April 2, 2019 – Shivom, a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, and Family Care Path (FCPI), a spin-off company from Cleveland Clinic adapting and marketing web-based clinical decision support applications, are collaborating to integrate FCPI’s MyLegacy application within Shivom’s marketplace. Through collaboration, Shivom’s customers can gain access to a personalised health risk profile and genomic counselling sessions which provide end-users with coaching to take proactive steps against hereditary conditions found within their genetic data.

FCPI has established an international telegenetic counselling network, branded CarePathConnect, which provides patients with the ability to privately and securely discuss their genetic health risk conditions with genetic counsellors and learn about the benefits and limitations of genetic testing via a HIPAA-compliant web-based video platform. The company exclusively licensed the family history collection and disease risk assessment tool from Cleveland Clinic, branded MyLegacy, which uses proprietary algorithms based on practice guidelines developed by the Cleveland Clinic Genomic Medicine Institute.

“Access to your genetic information is really just the beginning — using that information in combination with genetic counselling allows the necessary preventative measures to prevent serious health complications,” said Henry Ines, CEO of Shivom. “Our collaboration with Family Care Path enables Shivom’s customers to access their genetic information using a clinically validated programme to help them make lifestyle changes which seek to prevent or suppress hereditary conditions.”

The pilot for this collaboration will enable Shivom customers to access the FCP MyLegacy application and schedule a virtual genomic counselling session. Both clinical and non-clinical counselling sessions will be explored and processes will be established to ensure that customers are able to utilise both data collected from the FCP risk assessment tool as well as any genomic or other ‘omics’ reporting facilitated by Shivom subject to patient consent and permissions. Shivom also plans to arrange for its OMX token to be utilised as a means of payment and incentives for accessing counselling sessions and related services. The partnership marks a critical step in the roadmap for Shivom as it onboards key partners and services on its platform/marketplace to further demonstrate utility for its token.

“We are excited to collaborate with Shivom on this innovative effort. Working with Shivom will help their customers have a deeper understanding of their genetic information through testing, counselling and the ties to family health history” says David McKee, President and CEO of Family Care Path.

For more information about Shivom’s direct-to-consumer solutions please click here

About Shivom
Shivom is a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed. By utilising innovative technologies such as blockchain and machine-learning algorithms, we are able to democratise genomics.

Our mission is to bring exponential value to our end-users within the genomics industry. We believe that the unique combination of our in-depth knowledge for genomics, mixed with deep-rooted backgrounds in cryptography and AI is essential in the democratisation of genomics and healthcare data.

Shivom Social Channels:
● Official Homepage: shivom.io
● Twitter (English): @projectshivom
● Youtube: Shivom’s Channel
● Telegram: Shivom Announcements
● Facebook: @projectshivom
● Instagram: @projectshivom
● Medium: Shivom Official
● LinkedIn: @projectshivom

About Family Care Path
Family Care Path develops, adapts and markets web-based clinical software applications designed to improve patient outcomes, increase physician and clinical process efficiency, and interface with a variety of electronic health records.

Many exciting concepts for healthcare applications remain isolated within the development environment. Our company’s mission is to identify these opportunities and develop software solutions utilising industry standard protocols, to enable widespread adoption.

We utilise the latest technology to develop secure and scalable applications to improve the quality of healthcare and reduce cost. Leveraging industry standard technologies such as Microsoft Cloud and both the SMART® and HL7® FHIR® open standards, Family Care Path creates applications which can seamlessly communicate with all electronic health record systems.

For more information about Family Care Path please visit:
www.familycarepath.com

Recommended

Shivom-Alpha-2.0-Release

Shivom Releases Alpha 2.0 to Genomic Researchers & Data Owners

Shivom-Alpha-2.0-Release

Shivom – a data discovery and analysis solutions platform – on Tuesday unveiled its second release – Alpha 2.0. Leveraging the latest advancements in blockchain and machine-learning technology, Shivom is optimising how DNA is shared, secured and analysed in order to bring exponential value to the genomics industry.

In November 2018, Shivom launched its first release amid great enthusiasm and fervour. Since then, the product and development teams have been working on fixing bugs and integrating new features that have come from their recent partnership with Lifebit. In its first release, it streamlined its UI/UX and USPs based on the need to innovate in the area of secure storage. It also had multiple new-age features such as simplified sign-up DNA upload & encryption, etc.

Continuing its efforts in the area of innovation, Shivom continued developing on the previous release and has now launched its second release – Alpha 2.O. The latest advancements in the platform include avatars, issuing of notifications, bug-fixing throughout the platform, enterprise search functionality, an upgraded UI, and finally our blockchain transaction and verification for DNA file-uploading.

With the above-mentioned substantial updates, the platform can now verify via blockchain when a file is uploaded, secured and encrypted via Shivom. The next release titled ‘MVP’ will set to deliver DNA sequencing kits, an integrated wallet, marketplace and secure-sharing features. With a successful and well-tested second release, Shivom is steering itself into capturing a mega segment in this market.

About Shivom
Shivom is a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed. By utilising innovative technologies and pharmaceutical companies with the ability to securely share, store and analyse DNA data quickly, efficiently and at any scale. such as blockchain and machine-learning algorithms, we are able to democratise genomics. Doing so, we empower data-owners, researchers To learn more about the project, visit the Shivom website.

Shivom Social Channels:
● Official Homepage: shivom.io
● Twitter (English): @projectshivom
● Youtube: Shivom’s Channel
● Telegram: Shivom Community
● Facebook: @projectshivom
● Instagram: @projectshivom
● Medium: Shivom Official
● LinkedIn: @projectshivom

Recommended

World Sprint Champion Lion Martinez Joins Shivom Innovation Council

The M35 100-metre world sprint champion Lion Martinez joined Shivom Innovation Council (SIC) on February 1, 2019. Shivom is a biotechnology data and analysis company optimizing the way DNA is shared, secured and analysed. It leverages innovative technologies such as blockchain and machine-learning algorithms to democratize genomics.

Lion joining SIC marks the very first steps of Shivom into building a sport, athletics and well being initiative. The sports initiative will use state-of-the-art genomics and AI algorithms to develop science-based programs to make people fitter and perform on a higher level. The program seeks to identify from genetic bases as to what makes an athlete an, in turn, this data into meaningful insight for sports and fitness individuals who are interested in trying innovative and evidence-based training programs to improve their efficiencies. With his experience in athletics, Lion will play a key role in strategizing on the same.

SIC is an internal think tank at Shivom which supports and guides the senior management on the latest technologies, industry trends and strategies. It includes expert scientists, groundbreaking healthcare solution-providers, cyber security pioneers and genomics researchers. The council includes the likes of Taavi Roivas, former prime minister of Estonia and Antanas Guoga, a Lithuanian representative at the European Parliament. With Lion coming onboard, Shivom plans to foray into sports and well being soon.

Lion, who in his own words “likes cooking, gaming and toast”, has 20 years of experience in marketing, and brand and product management. He professional endeavours include working in various capacities with global companies such as Electronic Arts, Disney, Warner Brothers, Asus and Sony, among several others. Lion is presently the Global Product Manager of e-sport software company Wasder AB.

A former national and European-level athlete, Lion has numerous national gold medals (in 100-metre sprint) in his kitty. He was also the youngest-ever Swedish to have participated in the 2002 European Championships in Munich. Lion holds a 100-metre world championship gold medal (2016) and has numerous records and medals (in 60, 100 and 200-metre sprints) to his credit. Additionally, he has been involved in coaching, public speaking and widespread health issues and initiatives over the past 20 years, engaging with children, youth, adults and senior citizens alike. We believe he will become the torchbearer of the planned sports initiatives at Shivom.

About Shivom
Shivom is a biotechnology data and analysis company optimizing the way DNA is shared, secured and analysed. By utilizing innovative technologies such as blockchain and machine-learning algorithms, we are able to democratize genomics. Doing so, we empower data-owners, researchers and pharmaceutical companies with the ability to securely share, store and analyse DNA data quickly, efficiently and at any scale. For further information, please visit: https://www.shivom.io/

Recommended

The Cervical Cancer Awareness Month is here! How aware are you

Cervical Cancer Awareness Month is here! How aware are you?

The Cervical Cancer Awareness Month is here! How aware are you

How often have you come across a patient of cervical cancer around you? Chances are, rarely. But reality begs to differ. According to the World Health Organization (WHO), over six per cent women around the world (including 570,000 new cases) suffered from cervical cancer in 2018. Sadly, the statistics of both the developed and developing countries tell a similar horrifying story. Every day, nine women in the UK are diagnosed with cervical cancer and three lose their battles to life. In the US, nearly 13,000 women are diagnosed with cervical cancer every year, which amounts to an appalling 36 women falling prey every day! Developing countries like India have morbid statistics too. As per a study by National Center for Biotechnology Information, India alone accounts for a quarter of cervical cancer cases globally. Approximately 270,000 women across the world die from cervical cancer yearly, with 85 per cent deaths occurring in low-to-middle income countries. Owing to the gigantic figures, the United States Congress designated January as the Cervical Health Awareness Month.

Most common among women aged around 35 years, cervical cancer has remained, through times, an ignominious reality. However, even more lamentable is the fact that 75 per cent of such cases are actually prevented by cervical screening (or smear tests) and vaccination. Yet, one in four women does not attend this potentially life-saving test because of embarrassment. Some time back as part of the Pink Chain campaign, a study among schoolteachers in India was conducted. It revealed that cervical cancer was the second most common cancer in India. It also identified and assessed the level and impact of awareness programs in the adoption of safe practices in prevention and early detection. Uneasiness around discussing the topic with friends, family and peers emerged as the main reason behind women not coming forward for tests and treatment.

While cervical cancer rates have dropped significantly within the United States over the past few decades, it still remains a critical global health issue. The high mortality rate for cervical cancer in the developing world is driven by limited access to cervical cancer screening and treatment. Laboratory-based methods used to detect cervical cancer, and the personnel required to perform and analyse them may be unavailable in developing nations. In an alarming finding, it was identified that approximately 90 per cent of deaths from cervical cancer occurred in low- and middle-income countries. Likewise, the ability to treat cervical cancer is highly dependent on access to surgical facilities, chemotherapy agents and radiation equipment.

The high global mortality rate despite having mechanisms to diagnose and treat this cancer is a matter of great concern. Doctors and researchers have time and again emphasized that more awareness programs need to be run and sustained in order to literate people, especially women, to combat this cancer. Women must be encouraged to speak, walk up to a doctor and get her diagnosed. Reduction in mortality could be induced through a comprehensive approach which includes preventive care, early diagnosis, effective screening and treatment, and follow-ups. Particularly, in countries where screening programs are not available, identifying cervical cancer at an early stage and providing effective treatment can improve the likelihood of survival. Presently, in many low-income nations, the disease is often not identified until in advanced stages.

Widespread training and awareness programs run by state governments in partnership with CSR divisions of private firms can also be a way forward in combating cervical cancer. They must be made educated on the initial symptoms of the cancer. WHO Package of Essential non-communicable (PEN) disease interventions for primary healthcare in low-resource settings has guidance on the approach to assessing and referring affected women in the primary care setting. This must be widely publicized through various broadcast channels. In one of its studies, the WHO has concluded that “… screening should be performed at least once for every woman in the target age group (30-49 years) when it is most beneficial; HPV testing, cytology and visual inspection with acetic acid (VIA) are all recommended screening tests;  cryotherapy or loop electrosurgical excision procedure (LEEP) can provide effective and appropriate treatment for the majority of women who screen positive for cervical pre-cancer; “screen-and-treat” and “screen, diagnose and treat” are both valuable approaches.”

Irrespective of the approach being deployed in educating women, the key to an effective program is reaching the largest proportion of women at risk. Organized screening programs, comprehensive cervical cancer prevention and control, community education, social mobilization, vaccination, etc. can go a long way in improving cervical cancer control. Cervical Health Awareness Month is an opportunity to dedicated work, for a whole month, towards ensuring that our women remain safe and prevented from this deadly cancer. Let us spread the word around, not only among our female friends but also among our male friends, peers and family so that in case of such diagnosis, every person around must be aware of the next critical steps involved in treating the patient. Let us all be well-equipped for a better tomorrow because prevention is certainly better than cure.

Recommended